Crohn’s Disease - Risk and Microbial Marker Study

Risk Stratification and Identification of Immunogenetic and Microbial Markers of Rapid Disease Progression in Children with Crohn’s Disease

Protocol Description

The purpose of this study is to identify “bio-markers” easily found in blood, stool or in the lining of the intestines that can help doctors understand which children with Crohn’s Disease are at risk of developing complications quickly, enabling them to better treat patients.

Eligibility Criteria

Subject to certain exclusion criteria, boys and girls up to age 16 who have newly diagnosed or suspected Inflammatory bowel disease, also known as Crohn’s disease, ulcerative colitis or indeterminate colitis, will be asked to participate in the study.
Males: Up to age 16
Females: Up to age 16

During the initial visit, researchers will collect medical history information as well as blood and stool samples for analysis. Blood draws will also be done at the 3 annual follow-up visits. For patients scheduled for a routine colonoscopy with biopsy, there is a study option to collect a few additional biopsies for research purposes.
Visits: 4
Duration: 3 years

Status: Open for Enrollment

Source(s) of Support
Crohn’s and Colitis Foundation of America

Additional Information
Study Description at National Institutes of Health

Primary Investigator(s)

David J. Keljo, MD, PhD

Contact Information

For more information about this study or enrollment, please contact:
Donna Smith, RT, MS

Last Update
March 13, 2014
  • Increase/Decrease Text Size
  • Print This Page
Last Update
March 13, 2014